EMEA-000720-PIP01-09-M02

Key facts

Invented name
Xagrid
Active substance
Anagrelide
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0325/2013
PIP number
EMEA-000720-PIP01-09-M02
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of essential thrombocythaemia
Route(s) of administration
Oral use
Contact for public enquiries
Takeda Pharmaceuticals International AG Ireland Branch

E-mail: medinfoEMEA@takeda.com
Tel. +80066838470

Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000720-PIP01-09-M02
Compliance opinion date
14/02/2014
Compliance outcome
positive

Decision

Related content

How useful was this page?

Add your rating